O
EPIX

OrbiMed’s ESSA Pharma EPIX Stock Holding History

OrbiMed’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-842,366
Closed -$2.6M – 122
2023
Q3 		$2.6M Sell
842,366
-79,574
-9% -$229K 0.06% 108
2023
Q2 		$2.49M Sell
921,940
-276,397
-23% -$810K 0.05% 113
2023
Q1 		$3.56M Buy
1,198,337
+833,037
+228% +$2.45M 0.07% 110
2022
Q4 		$921K Sell
365,300
-275,345
-43% -$790K 0.02% 111
2022
Q3 		$1.17K Buy
+640,645
New +$1.69M 0.02% 125
2021
Q1 		– Sell
-460,500
Closed -$5.49M – 170
2020
Q4 		$5.49M Sell
460,500
-716,983
-61% -$5.05M 0.05% 138
2020
Q3 		$8.13M Sell
1,177,483
-294,370
-20% -$2M 0.1% 113
2020
Q2 		$9.13M Hold
1,471,853
– – 0.13% 103
2020
Q1 		$5.89M Hold
1,471,853
– – 0.1% 101
2019
Q4 		$8.1M Hold
1,471,853
– – 0.12% 87
2019
Q3 		$4.96M Buy
+1,471,853
New +$3.63M 0.1% 95

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return